Document Detail


RET protein expression in papillary renal cell carcinoma.
MedLine Citation:
PMID:  21396847     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE:: To examine the role of RET in renal malignancy, in particular papillary renal cell carcinoma (RCC). MATERIALS AND METHODS:: A cohort of 111 archival renal samples was used consisting of 94 renal cancers (66 papillary RCC, 18 conventional clear cell carcinoma, 10 chromophobe RCC), 4 benign oncocytomas, and 13 normal kidney tissues. RET protein expression was examined by immunohistochemistry and expression levels were correlated with clinicopathologic and patient survival data. RESULTS:: Positive RET staining was seen in 34/66 (52%) papillary RCCs, 4/10 (40%) chromophobe carcinomas, 4/4 (100%) oncocytomas, and 11/13 (85%) normal kidney samples. All 18 cases of conventional clear cell carcinoma had negative RET staining. RET expression was associated with low Fuhrman nuclear grade. CONCLUSIONS:: RET protein may be contributing in part to an adaptation of a papillary growth pattern in certain renal malignancies. Given the possible therapeutic benefit of small molecule inhibitors of RET activation, further work needs to be done to highlight the functional relevance of RET protein expression in papillary RCC.
Authors:
Richard Flavin; Stephen P Finn; Toni K Choueiri; Helen Ingoldsby; Martina Ring; Ciara Barrett; Miranda Rogers; Paul Smyth; Esther O'Regan; Eoin Gaffney; John J O'Leary; Massimo Loda; Sabina Signoretti; Orla Sheils
Related Documents :
10226857 - Enhanced renal vasoconstrictor responsiveness to vasopressin after renal denervation.
21233617 - Bone marrow-derived mesenchymal stem cells transplantation accelerates tissue expansion...
10192247 - Renin-angiotensin genes in renal development and the occurrence and progression of rena...
19482677 - Chemokines and chemokine receptors as therapeutic targets in chronic kidney disease.
11112067 - Long-term small bowel allograft function induced by short-term fk 506 application is as...
21734227 - Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-9
Journal Detail:
Title:  Urologic oncology     Volume:  -     ISSN:  1873-2496     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805460     Medline TA:  Urol Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Histopathology, St. James's Hospital, Dublin, Ireland; The Department of Pathology, National University of Ireland, Galway, Ireland; The Dana Farber Cancer Institute, Boston, MA 02115, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The predominance of benign histology in small testicular masses.
Next Document:  Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing...